Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.

about

Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.

Item

http://www.wikidata.org/entity/Q39047609

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effective suppression of atria ...... a novel antiarrhythmic agent.

@en

Effective suppression of atria ...... a novel antiarrhythmic agent.

@nl

type

Item

label

Effective suppression of atria ...... a novel antiarrhythmic agent.

@en

Effective suppression of atria ...... a novel antiarrhythmic agent.

@nl

prefLabel

Effective suppression of atria ...... a novel antiarrhythmic agent.

@en

Effective suppression of atria ...... a novel antiarrhythmic agent.

@nl

P1476

Effective suppression of atria ...... a novel antiarrhythmic agent.

@en

P2093

Christian Pott

http://www.w3.org/2001/XMLSchema#string

Dirk G Dechering

http://www.w3.org/2001/XMLSchema#string

Harilaos Bogossian

http://www.w3.org/2001/XMLSchema#string

Magdalena Sterneberg

http://www.w3.org/2001/XMLSchema#string

Michael Fehr

http://www.w3.org/2001/XMLSchema#string

Peter Milberg

http://www.w3.org/2001/XMLSchema#string

Sven Kaese

http://www.w3.org/2001/XMLSchema#string

P2860

Dronedarone in High-Risk Permanent Atrial Fibrillation

Verapamil prevents stretch-induced shortening of atrial effective refractory period in langendorff-perfused rabbit heart.

Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations

Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation

Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).

Atrial remodeling and atrial fibrillation: mechanisms and implications.

Novel molecular targets for atrial fibrillation therapy.

Interaction between digoxin and dronedarone in the PALLAS trial.

P31

scholarly article

P356

10.1111/1755-5922.12244

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lars Eckardt

Gerrit Frommeyer

Nils Bögeholz

P577

2016-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28039911

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation